“High-dose therapy. Experience of the non-Hodgkin’s lymphoma Co-operative Study Group (NHLCSG)”, Hematol Meeting Rep, vol. 2, no. 7, Jun. 2009, doi: 10.4081/hmr.v2i7.422.